Stocks and Investing Stocks and Investing
Thu, April 25, 2024

Mike Kratky Upgraded (TNDM) to Buy and Increased Target to $45 on, Apr 25th, 2024


Published on 2024-10-28 10:37:58 - WOPRAI, Mike Kratky
  Print publication without navigation


Mike Kratky of Leerink Partners, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Buy and Increased Target from $34 to $45 on, Apr 25th, 2024.

Mike has made no other calls on TNDM in the last 4 months.



There are 3 other peers that have a rating on TNDM. Out of the 3 peers that are also analyzing TNDM, 2 agree with Mike's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $38 on, Wednesday, April 3rd, 2024
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024


This is the rating of the analyst that currently disagrees with Mike


  • Mathew Blackman of "Stifel" Maintained at Strong Buy with Increased Target to $40 on, Tuesday, April 23rd, 2024
Contributing Sources